The Remember Me feature is an automatic login process which creates a cookie on the hard drive of your computer containing a unique identifier which ASCO.org will utilize to remember you by, thereby avoiding the need to enter username and password upon subsequent visits to ASCO.org. DO NOT select this option if you share this computer with others since transactional, personal, or member only information will be accessible by other users.
To activate the Remember Me option, click the empty check box when signing in to the site. The Remember Me functionality is deactivated at the logout.
For additional information please review our Privacy Policy.
In this News Digest, you will find a summary of a study published online January 25, 2010, in the Journal of Clinical Oncology, showing that progression-free survival in patients with advanced renal cell carcinoma who received pazopanib (VOTRIENT) was more than twice as long as in those who received a placebo.
ALEXANDRIA, Va. – The Journal of Clinical Oncology (JCO) announced today that Stephen A. Cannistra, MD, Professor of Medicine at Harvard Medical School, will become Editor-in-Chief of JCO effective May 2011.
ALEXANDRIA, Va. - A summary of study being published online November 23, 2009, in the Journal of Clinical Oncology, showed that insomnia was more than twice as common among patients undergoing chemotherapy for cancer than in the general population.
ALEXANDRIA, Va. – The Journal of Clinical Oncology (JCO) is celebrating the publication of its 500th issue. The tri-monthly peer-reviewed journal of the American Society of Clinical Oncology (ASCO) will reach this milestone with its November 10, 2009, edition.
ALEXANDRIA, Va. - Summaries of two studies being published online November 2, 2009, in the Journal of Clinical Oncology showing that women with small, HER2-positive breast cancers that had not spread to the lymph nodes had an elevated risk of recurrence and metastasis compared with women with small HER2-negative node-negative breast cancers.
ALEXANDRIA, Va. – Today, in a major step toward ensuring high-quality care for people with cancer, two major medical associations are releasing the first-ever national standards for safe administration of chemotherapy drugs. These policies seek to serve as a benchmark for providers of adult cancer care and encourage them to evaluate their current standards.
ALEXANDRIA, Va - A study conducted by the American Society of Clinical Oncology (ASCO) finds that different interpretations of the U.S. Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule can result in significant delays or abandonment of important clinical cancer research projects. The study also outlines measures that research sites can undertake to resolve these differences and speed the pace of research.
Orlando, Fla. – The American Society of Clinical Oncology (ASCO) today announced the Quality Oncology Practice Initiative (QOPI®) Certification Program, a new program to certify oncology practices that achieve rigorous standards for high-quality cancer care.
Alexandria, Va. — A newly updated guideline from the American Society of Clinical Oncology (ASCO) states that post-menopausal women who are at increased risk for breast cancer could benefit from taking either tamoxifen or raloxifene to reduce their risk of developing the disease.
A summary of a study published online March 16, 2009 in the Journal of Clinical Oncology showed that high levels of C-reactive protein, a marker for inflammation and heart disease risk, may also be associated with the risk of developing cancer and with earlier cancer death.
